FDA approves Roche DNA test for transplant patients to improve post-surgery recovery

The U.S.Food and Drug Administration has approved a DNA test to ascertain how transplant patients respond to treatment for cytomegalovirus or CMV, according to an FDA statement, to improve post-surger…
Read the full story: MedCity News